# Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin

Study · id `cardio:ct-nct01517412` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01517412](<https://clinicaltrials.gov/study/NCT01517412>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01517412

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 451 participants.

## Technical summary

Registry record NCT01517412. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-05 (actual). Results posted on 2016-10-14.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 451 participants (enrolled count; ClinicalTrials.gov record NCT01517412, source copy `cardio:ctgov-nct01517412-2016-10-14`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT01517412, source copy `cardio:ctgov-nct01517412-2016-10-14`, retrieved 2026-10-26)
- Primary completion: 2013-05 (actual) (ClinicalTrials.gov record NCT01517412, source copy `cardio:ctgov-nct01517412-2016-10-14`, retrieved 2026-10-26)
- Completion: 2013-05 (actual) (ClinicalTrials.gov record NCT01517412, source copy `cardio:ctgov-nct01517412-2016-10-14`, retrieved 2026-10-26)
- Results first posted: 2016-10-14 (ClinicalTrials.gov record NCT01517412, source copy `cardio:ctgov-nct01517412-2016-10-14`, retrieved 2026-10-26)
- Countries: United States; Canada; Czechia; France; Germany; Poland; Romania; Russia; Spain; Ukraine (ClinicalTrials.gov record NCT01517412, source copy `cardio:ctgov-nct01517412-2016-10-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01517412-2016-10-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Lixisenatide (AVE0010)
- Intervention (Device): Self-injector pen device (OptiClik®)
- Intervention (Drug): Metformin
- Lead sponsor: Sanofi
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Sanofi (`cardio:org-sanofi`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day (`cardio:pubmed-25012990`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 58b8f45ff8fde0207d04fd602cd487c937464f331051722dd05e99b0538f7ff4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
